1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,022 | 0,024 | 11:10 |
Chart-Typ:
Zeitraum:
| CRISPR Therapeutics AG: CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results | ZUG, Switzerland and BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the second quarter ended June 30, 2026. "The second quarter reflected... ► Artikel lesen |
| Morningstar, Inc.: Morningstar Completes Rebrand of CRSP Market Indexes to Morningstar Market Indexes | Indexes underpinning more than $3 trillion in investor assets move under the Morningstar brand, expanding visibility and supporting future growth
Morningstar, Inc. (NASDAQ: MORN), a leading provider... ► Artikel lesen |
| CRISPR Therapeutics: 12 Monate voller Kurskatalysatoren - Chance mit hohem Risiko für Gen-Editing-Investoren | CRISPR Therapeutics steht vor einem "catalyst-rich 12 months ahead?, in denen mehrere klinische und regulatorische Meilensteine das Chance-Risiko-Profil der Aktie neu justieren könnten. Im Mittelpunkt... ► Artikel lesen |
| Ionis Pharmaceuticals, Inc.: Ionis to present new data strengthening leadership in the management of severe hypertriglyceridemia (sHTG) at the European Society of Cardiology Congress 2026 | Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that new data in the management of severe hypertriglyceridemia (sHTG) will be presented at the European Society of Cardiology (ESC) Congress... ► Artikel lesen |
| Weekly Buzz: Johnson & Johnson, Vera Therapeutics Get FDA Nod; Vertex Pharmaceuticals Snaps Up Crinetics Pharmaceuticals; Satellos Bioscience Aces DMD Trial; Ionis Pharmaceuticals Misses Key Goal | NEW BRUNSWICK (dpa-AFX) - This week featured a steady stream of regulatory milestones, strategic dealmaking, and pivotal clinical trial updates, alongside missed trial goals across the biotech... ► Artikel lesen |
| Aktien New York Schluss: Chip-Aktien treiben Nasdaq hoch | NEW YORK (dpa-AFX) - Trotz zunehmender militärischer Auseinandersetzungen zwischen den Vereinigten Staaten und dem Iran haben die US-Aktienmärkte am Donnerstag Kursgewinne verzeichnet. Vor allem Papiere... ► Artikel lesen |
| PacBio Appoints Mark Van Oene as President and Chief Executive Officer | MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) ("PacBio"), a leading developer of high-quality, highly accurate sequencing solutions,... ► Artikel lesen |
| PacBio Announces Second Quarter 2026 Financial Results | MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2026. Recent Business Highlights Total revenue of $39.0... ► Artikel lesen |
| PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system | MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced the upcoming availability of SPRQ-Nx chemistry... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GENFLOW BIOSCIENCES PLC finden Sie auf Wallstreet Online.